Inflammation and overweight in peritoneal dialysis: Is there an association

Renal Failure

Volumn 31, Issue 7, 2009, Pages 549-554

  De Araujo Antunes, Aline ^a   Vannini, Francieli Delatim ^a   Martin, Luis Cuadrado ^a   Balbi, Andre Luis ^a   Ponce, Daniela ^a   Nunes, Hélio Rubens ^b   Barretti, Pasqual ^a   Caramori, Jacqueline Costa Teixeira ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Body fat; Dialysis; Inflammation; Lymphocytes count; Nutritional state; Overweight

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; FERRITIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTHROPOMETRY; ARTICLE; BODY FAT; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; IMPEDANCE; INFLAMMATION; LYMPHOCYTE COUNT; MALE; NUTRITION; OBESITY; PERITONEAL DIALYSIS; PRIORITY JOURNAL;

ADULT; AGED; BLOOD CHEMICAL ANALYSIS; BODY COMPOSITION; BODY MASS INDEX; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; CYTOKINES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFLAMMATION; INFLAMMATION MEDIATORS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; NUTRITION ASSESSMENT; OVERWEIGHT; PERITONEAL DIALYSIS; PROBABILITY; REFERENCE VALUES; RISK ASSESSMENT; TUMOR NECROSIS FACTOR-ALPHA;

EID: 72649085358     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220903050397     Document Type: Article

References (36)

1. Chung SH, Heimburger O, Stenvinkel P, Rashid A, Lindholm B. Association between residual renal function, inflammation and patient survival in new peritoneal dialysis patients. Nephrol Dial Transplant. 2003;18:590-597.
2. Ávila-Díaz M, Ventura M, Valle D, et al. Inflammation and extracellular volume expansion are related to sodium and water removal in patients on peritoneal dialysis. Perit Dial Int. 2006;26:574-580.
3. Pecoits-Filho R, Barany P, Linholm B, Heimburger O, Stenvinkel P. Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant. 2002;17:1684-1688.
4. Cueto-Manzano AM, González-Espínoza L, Campo FM, Fortes PC, Pecoits-Filho R. Inflammation in peritoneal dialysis: A Latin-American perspective. Perit Dial Int. 2007;27:347-352
5. Trayhurn P, Wood IS. Adipokines: Inflammation and the pleiotropic role of white adipose tissue. BJN. 2004;92:347-355.
6. Pennell P, Rojas C, Asif A, Rossini E. Managing metabolic complications of peritoneal dialysis. Clin Nephrol. 2004;62:35-43.
7. Jolly S, Chatatalsingh C, Bargman J, Vas S, Chu M, Oreopoulos DG. Excessive weight gain during peritoneal dialysis. Int J Artif Organs. 2001;24:197-202.
8. McDonald SP, Collins JF, Johnson DW. Obesity is associated with worse peritoneal dialysis outcomes in the Australia and New Zealand patient populations. J Am Soc Nephrol. 2003;14:2894-2901.
9. Ramkumar N, Pappas LM, Beddhu S. Effect of body size and body composition on survival in peritoneal dialysis patients. Perit Dial Int. 2005;25:461-469. (Pubitemid 41448401)
10. Kalantar-Zadeh K, Abbott KC, Salahudeen AK, Kilpatrick RD, Horwich TB. Survival advantages of obesity in dialysis patients. Am J Clin Nutr. 2005;81:543-554.
11. Mafra D, Farage NE. O papel do tecido adiposo na doença renal crônica. J Bras Nefrol. 2006;28:108-113.
12. Beddhu A, Pappas LM, Ramkumar N, Samore M. Effects of body size and body composition on survival in hemodialysis patients. J Am Soc Nephrol. 2003;14:2366-2372.
13. Durnin JVGA, Womersley J. Body fat assessment from total body density and its estimation from skinfold thickness: Measurements on 481 men and women aged 16 to 72 years. Br J Nutr. 1974;32:77-97.
14. Siri WE. Body composition from fluid spaces and density: Analysis of methods. University of California Radiation Laboratory publication 3349. Berkeley, Calif.;1956.
15. Grant JP, Custer PB, Thurlow J. Current techniques of nutritional assessment. Surg Clin North Am. 1981;61:463-473.
16. Frisancho AR. New norms of upper limb fat and muscle areas for assessment of nutritional status. Am J Clin Nutr. 1981;34:2540-2545.
17. NKF/KDOQI. Clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis. 2000;35:S17.
18. Kalantar-Zadeh K, Block G, McAllister CJ, Humpreys MH, Kopple JD. Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients. Am J Clin Nutr. 2004;80:299-307.
19. Chandalia M, Abate N. Metabolic complications of obesity: Inflated or inflamed? J Diabetes Complications. 2007;21:128-136.
20. Wang AY, Woo J, Lam CW, et al. Is a single time point Creactive protein predictive of outcome in peritoneal dialysis patients? J Am Soc Nephrol. 2003;14:1871-1879.
21. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999;282:2131-2135.
22. Pannacciulli N, Cantatore FP, Minenna A, Bellacicco M, Giorgino R, Pergola G. C- reactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women. Int J Obes. 2001;25:1416-1420.
23. Axelsson J, Qureshi AR, Suliman ME, et al. Truncal fat mass as a contributor to inflammation in end-stage renal disease. Am J Clin Nutr. 2004;80:1222-1229.
24. Snyder JJ, Foley RN, Gilbertson DT, Vonesh EF, Collins AJ. Body size and outcomes on peritoneal dialysis in the United States. Kidney Int. 2003;64:1838-1844.
25. Fried L, Bernardini J, Piraino B. Neither size nor weight predicts survival in peritoneal dialysis patients. Perit Dial Int. 1996;16:357-361.
26. Aslam N, Bernardini J, Fried L, Piraino B. Large body mass index does not predict short-term survival in peritoneal dialysis patients. Perit Dial Int. 2002;22:191-196.
27. Carvounis CP, Manis T, Coritsidis G, Dubinski M, Serpente P. Total lymphocyte count: A promising prognostic index of mortality in patients on CAPD. Perit Dial Int. 2000;20:33-38.
28. Ates K, Ates A, Kutlay S, Nergizogi G, Karatan O. Total lymphocyte count in peripheral blood of peritoneal dialysis patients: Relationship to clinical parameters and outcome. J Nephrol. 2004;17:246-252.
29. Reddan DN, Klassen PS, Szczech LA, et al. White blood cells as a novel mortality predictor in haemodialysis patients. Nephrol Dial Transplant. 2003;18:1167-1173.
30. Sayarlioglu H, Erkoc R, Demir C, et al. Nutritional status and immune functions in maintenance hemodialysis patients. Mediators Inflamm. 2006;2006:1-4.
31. Lacson Jr E, Levin NW. C-reactive protein and end-stage renal disease. Semin Dial. 2004;17:438-448.
32. Bulló M, Garcia-Lorda P, Megias I, Salas-Salvadó J. Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obes Res. 2003;11:525-531.
33. Zoccalli C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Perlongo S. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol. 2002;13:134-141. (Pubitemid 34042020)
34. Malyszko J, Malysko J, Wolczynski S, Mysliwiec M. Adiponectin, leptin and thyroid hormones in patients with chronic renal failure and on renal replacement therapy: Are they related? Nephrol Dial Transplant. 2006;21:145-152.
35. Guebre-Egziabher F, Drai J, Fouque D. Adiponectin and chronic kidney disease. J Ren Nutr. 2007;17:9-12.
36. Kalantar-Zadeh K, Rodriguez RA, Humphreys MH. Association between serum ferritin and measures of inflammation, nutrition and iron in hemodialysis patients. Nephrol Dial Transplant. 2004;19:141-149.